Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

NCT01927835 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: DNA-HIV-PT123 vaccine
BIOLOGICAL: NYVAC-HIV-PT1 vaccine
BIOLOGICAL: NYVAC-HIV-PT4 vaccine
BIOLOGICAL: AIDSVAX B/E vaccine
BIOLOGICAL: Placebo for DNA/NYVAC/AIDSVAX

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]